Joseph Mannello is the CEO of MYOS RENS Technology Inc. (NASDAQ: MYOS), in Cedar Knolls, NJ, a research-based company focused on addressing musculoskeletal health through the development and commercialization of advanced nutrition products for both humans and pets. Previously, from March 2013 to May 2015, Mr. Mannello was the Executive Managing Director at Brean Capital LLC, an independent investment bank and asset management firm, also serving as member of the firm’s operating committee. From March 2008 to March 2012, Mr. Mannello was Head of corporate credit for Gleacher & Company, Inc. (OTC:GLCH), a publicly-traded investment bank. Prior to that, he was Head of the Fixed Income Division of BNY Capital Markets, Inc., a subsidiary of The Bank of New York Mellon Corp. (NYSE:BK). In March of 1998 Joe and his partners sold their firm Mendham Capital Group to BNY.